SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 928.79 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 11,108.86 |
| Book Value / Share | 11.36 |
| Price / Book | n/a |
| NCAV ($M) | 81.84 |
| NCAV / Share | 0.08 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.12 |
| Return on Assets (ROA) | 0.11 |
| Return on Equity (ROE) | 0.23 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.29 |
| Current Ratio | 1.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 13,053.36 |
| Assets | 24,080.38 |
| Liabilities | 12,971.52 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 18,606.90 |
| Operating Income | 3,982.47 |
| Net Income | 2,137.30 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 3,033.72 |
| Cash from Investing | -731.97 |
| Cash from Financing | -1,591.04 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| GLUC – Glucose Health, Inc. | GNCAQ – Genocea Biosciences, Inc. |
| GNFTF – Genfit S.A. | GNMSF – Genmab A/S |
| GNTLF – Genetic Technologies Limited |
Financial data and stock pages provided by
Fintel.io